Project Grant HT94252310395
Award Date
4/15/23
Completion Date
4/14/26
Dollars Obligated
$872K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...
The Department of the Army Medical Command awarded a $1,324,049 Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to identify neuronal signatures that distinguish Fragile X syndrome (FXS) patients with distinct electroencephalogram (EEG) phenotypes. The four-year award beginning August 1, 2022 will support research to investigate medical solutions for the battlefield by transforming healthcare through innovative...
The Department of the Army Medical Command awarded a $1,724,662 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify neuronal signatures that distinguish Fragile X syndrome patients exhibiting distinct electroencephalogram phenotypes. The University of Wisconsin System, doing business as Research and Sponsored Programs, will perform the work over a four-year period ending July...
The University of Illinois was awarded a $293,978 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Cognition, Vascular Function, and Physical Activity in Multiple Sclerosis," will fund research investigating innovative approaches to understanding and managing neurological conditions relevant to military personnel and veterans. The project, with a performance period from November 1, 2024 to October 31,...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
This $315,958 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Rush University Medical Center to investigate the neural underpinnings of the relationship between cognitive and gait dysfunction in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The award period runs from September 30, 2024 to September 29, 2026. This research aims to transform health care for...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $799,496 project grant to the University of Illinois to conduct the research project "Environmental Disruption of Metabolism: Neurocognitive Consequences a Therapeutic Intervention". The award period runs from September 30, 2023 to September 29, 2025. The objective of this research is to investigate the neurocognitive impacts of environmental disruptions to metabolism and develop...
This federal Project Grant award in the amount of $1,599,997.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award is for a clinical trial to research multiple sclerosis, with a performance period from September 1, 2024 to August 31, 2027. The University of Illinois, a major public research university, is the awardee and will serve as the primary research institution conducting this multi-year clinical trial....
The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
This is a Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The $1,148,034.00 award, with a period of performance from September 15, 2024 to September 14, 2027, will fund the University of Illinois to develop objective biomarkers and novel treatment strategies for hidden hearing loss and hyperacusis. As a prominent research institution, the University of Illinois has extensive experience in conducting...